Page 91 - Read Online
P. 91

Page 268               Thomas et al. J Transl Genet Genom 2024;8:249-77  https://dx.doi.org/10.20517/jtgg.2024.15

               Copyright
               The Author(s) 2024.


               REFERENCES
               1.       Cunha GR, Donjacour AA, Cooke PS, et al. The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8:338-
                    62.  DOI
               2.       Kumar VL, Majumder PK. Prostate gland: structure, functions and regulation. Int Urol Nephrol 1995;27:231-43.  DOI  PubMed
               3.       Singh O, Bolla SR. Anatomy, abdomen and pelvis, prostate. Treasure Island: StatPearls; 2023. Available from: https://www.ncbi.nlm.
                    nih.gov/books/NBK540987/ [Last accessed on 22 Jul 2024].
               4.       Rawla P. Epidemiology of prostate cancer. World J Oncol 2019;10:63-89.  DOI  PubMed  PMC
               5.       Schrecengost R, Knudsen KE. Molecular pathogenesis and progression of prostate cancer. Semin Oncol 2013;40:244-58.  DOI
                    PubMed  PMC
               6.       Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024;74:12-49.  DOI  PubMed
               7.       Shore ND, Moul JW, Pienta KJ, Czernin J, King MT, Freedland SJ. Biochemical recurrence in patients with prostate cancer after
                    primary definitive therapy: treatment based on risk stratification. Prostate Cancer Prostatic Dis 2024;27:192-201.  DOI  PubMed
                    PMC
               8.       Krušlin B, Ulamec M, Tomas D. Prostate cancer stroma: an important factor in cancer growth and progression. Bosn J Basic Med Sci
                    2015;15:1-8.  DOI  PubMed  PMC
               9.       Levesque C, Nelson PS. Cellular constituents of the prostate stroma: key contributors to prostate cancer progression and therapy
                    resistance. CSH Perspect Med 2018;8:a030510.  DOI  PubMed  PMC
               10.       Pederzoli F, Raffo M, Pakula H, Ravera F, Nuzzo PV, Loda M. Stromal cells in prostate cancer pathobiology: friends or foes? Br J
                    Cancer 2023;128:930-9.  DOI  PubMed  PMC
               11.       Barron  DA,  Rowley  DR.  The  reactive  stroma  microenvironment  and  prostate  cancer  progression.  Endocr  Relat  Cancer
                    2012;19:R187-204.  DOI  PubMed  PMC
               12.       Davey RA, Grossmann M. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev 2016;37:3-
                    15.  PubMed  PMC
               13.       Wen S, Chang HC, Tian J, Shang Z, Niu Y, Chang C. Stromal androgen receptor roles in the development of normal prostate, benign
                    prostate hyperplasia, and prostate cancer. Am J Pathol 2015;185:293-301.  DOI  PubMed  PMC
               14.       Cunha GR. Epithelio-mesenchymal interactions in primordial gland structures which become responsive to androgenic stimulation.
                    Anat Rec 1972;172:179-95.  DOI  PubMed
               15.       Schauer IG, Rowley DR. The functional role of reactive stroma in benign prostatic hyperplasia. Differentiation 2011;82:200-10.  DOI
                    PubMed  PMC
               16.       Schauer IG, Ressler SJ, Tuxhorn JA, Dang TD, Rowley DR. Elevated epithelial expression of interleukin-8 correlates with
                    myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 2008;72:205-13.  DOI  PubMed  PMC
               17.       Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of
                    myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002;8:2912-23.  PubMed
               18.       Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol 2001;166:2472-83.  DOI  PubMed
               19.       Kai F, Drain AP, Weaver VM. The extracellular matrix modulates the metastatic journey. Dev Cell 2019;49:332-46.  DOI  PubMed
                    PMC
               20.       Valkenburg KC, de Groot AE, Pienta KJ. Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin Oncol 2018;15:366-
                    81.  DOI  PubMed  PMC
               21.       Puré E, Lo A. Can targeting stroma pave the way to enhanced antitumor immunity and immunotherapy of solid tumors? Cancer
                    Immunol Res 2016;4:269-78.  DOI  PubMed  PMC
               22.       Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013;19:1423-37.  DOI  PubMed
                    PMC
               23.       Xiao Z, Todd L, Huang L, et al. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and
                    immunosuppression in solid tumors. Nat Commun 2023;14:5110.  DOI  PubMed  PMC
               24.       Zhang FF, Qiao Y, Xie Y, et al. Epitope-based minigene vaccine targeting fibroblast activation protein α induces specific immune
                    responses and anti-tumor effects in 4 T1 murine breast cancer model. Int Immunopharmacol 2022;112:109237.  DOI
               25.       Gorbach IN, Novikov DK. [Detection of leukocyte sensitization to tuberculosis mycobacterial antigens in newborns by the method of
                    migration suppression in vitro]. Vopr Okhr Materin Det 1976;21:66-8.  PubMed
               26.       Giacomini A, Grillo E, Rezzola S, et al. The FGF/FGFR system in the physiopathology of the prostate gland. Physiol Rev
                    2021;101:569-610.  DOI
               27.       Cunha GR. Mesenchymal-epithelial interactions: past, present, and future. Differentiation 2008;76:578-86.  DOI  PubMed
               28.       Roberson KM, Edwards DW, Chang GC, Robertson CN. Isolation and characterization of a novel human prostatic stromal cell
                    culture: DuK50. In Vitro Cell Dev Biol Anim 1995;31:840-5.  DOI  PubMed
               29.       Webber MM, Trakul N, Thraves PS, et al. A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial
                    interactions in prostatic neoplasia. Carcinogenesis 1999;20:1185-92.  DOI
   86   87   88   89   90   91   92   93   94   95   96